KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Tax Provisions: 2009-2024

Historic Tax Provisions for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to $47.7 million.

  • Emergent BioSolutions' Tax Provisions fell 76.81% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year decrease of 23.08%. This contributed to the annual value of $47.7 million for FY2024, which is 62.80% up from last year.
  • Per Emergent BioSolutions' latest filing, its Tax Provisions stood at $47.7 million for FY2024, which was up 62.80% from $29.3 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Tax Provisions ranged from a high of $106.1 million in FY2020 and a low of -$7.4 million during FY2022.
  • Moreover, its 3-year median value for Tax Provisions was $29.3 million (2023), whereas its average is $23.2 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Tax Provisions tumbled by 108.84% in 2022, and later soared by 495.95% in 2023.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Tax Provisions stood at $106.1 million in 2020, then declined by 21.11% to $83.7 million in 2021, then tumbled by 108.84% to -$7.4 million in 2022, then soared by 495.95% to $29.3 million in 2023, then soared by 62.80% to $47.7 million in 2024.